These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6299011)

  • 1. Impact of cytomegalovirus testing on blood collection facilities.
    Silvergleid AJ; Kott TJ
    Vox Sang; 1983; 44(2):102-5. PubMed ID: 6299011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HLA antigens are associated in seronegativity to cytomegalovirus(CMV)].
    Machida S; Takahashi T; Nomoto K; Murata S
    Nihon Rinsho; 1998 Jan; 56(1):129-33. PubMed ID: 9465677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of cytomegalovirus antibody in Thai-northeastern blood donors.
    Urwijitaroon Y; Teawpatanataworn S; Kitjareontarm A
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():180-2. PubMed ID: 7886568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomegalovirus DNA can be detected in peripheral blood mononuclear cells from all seropositive and most seronegative healthy blood donors over time.
    Larsson S; Söderberg-Nauclér C; Wang FZ; Möller E
    Transfusion; 1998 Mar; 38(3):271-8. PubMed ID: 9563407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antibody to cytomegalovirus-induced early antigens and comparison with four serologic assays and presence of viruria in blood donors.
    Lentz EB; Dock NL; McMahon CA; Fiesthumel SR; Arnold CB; Lamberson HV
    J Clin Microbiol; 1988 Jan; 26(1):133-5. PubMed ID: 2830297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological screening for the prevention of transfusion-acquired cytomegalovirus infection.
    Musiani M; Zerbini M; Carpi C; Plazzi M; Sermasi G; Belletti D; Sacchi R
    J Infect; 1984 Sep; 9(2):148-52. PubMed ID: 6094671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytomegalovirus diagnosis in blood donors and risk patients].
    Sibrowski W; Kühnl P; Kalmar G; Albert S; Böhm BO; Doerr HW
    Beitr Infusionsther; 1990; 26():37-9. PubMed ID: 1703874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CMV screening with the latex agglutination test in blood donors. Comparison between EIA and latex agglutination].
    Müller R; Milbradt H
    Beitr Infusionsther; 1990; 26():43-5. PubMed ID: 1703892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Blood donor selection in providing anticytomegalovirus-negative blood components].
    Koerner K; Freudenberg J; Kubanek B
    Dtsch Med Wochenschr; 1989 Feb; 114(6):203-7. PubMed ID: 2537170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antibodies to cytomegaloviruses in blood donors].
    Courault K; Lissé I; Richter H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):183-6. PubMed ID: 2475395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytomegalovirus seronegative platelets and leukocyte-poor red blood cells from random donors can prevent primary cytomegalovirus infection after bone marrow transplantation.
    Verdonck LF; de Graan-Hentzen YC; Dekker AW; Mudde GC; de Gast GC
    Bone Marrow Transplant; 1987 Jun; 2(1):73-8. PubMed ID: 2844337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Presence of anti-CMV antibodies in the sera of blood donors].
    Kazimierska E; Górski J
    Wiad Lek; 1988 Oct; 41(19):1271-3. PubMed ID: 2854686
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of transfusion-associated cytomegalovirus infection in very low-birthweight infants using frozen blood and donors seronegative for cytomegalovirus.
    Adler SP; Lawrence LT; Baggett J; Biro V; Sharp DE
    Transfusion; 1984; 24(4):333-5. PubMed ID: 6087517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with a "rapid test" in detecting antibodies to cytomegalovirus].
    Milbradt H
    Klin Wochenschr; 1989 Aug; 67(16):839-40. PubMed ID: 2552223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of cytomegalovirus antibodies in Thai blood donors.
    Kositanont U; Wasi C; Chandanayingyong D; Thongcharoen P
    Asian Pac J Allergy Immunol; 1985 Dec; 3(2):179-82. PubMed ID: 3000401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of cytomegalovirus in blood donation].
    Albert S; Kühnl P; Sibrowski W; Seidl S; Doerr HW
    Infusionstherapie; 1990 Feb; 17(1):48-56. PubMed ID: 2159951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of specific antibodies to cytomegalovirus in the blood donors in Qingdao].
    Zhao CQ; Shao JJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1989 Apr; 10(2):78-81. PubMed ID: 2544278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is serologic screening necessary in the donor bloods for cytomegalovirus seronegative blood transfusion to risky patients?].
    Mutlu B; Günlemez A; Türker G; Gökalp AS; Willke A
    Mikrobiyol Bul; 2008 Apr; 42(2):337-41. PubMed ID: 18697432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Persistence of antibodies of the IgG class against cytomegaloviruses in blood donors].
    Eichler C; Kaden J; Blauärmel O; Zimmermann G; Adamczyk G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):560-9. PubMed ID: 2446998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cytomegalovirus seronegative blood donors: studies of the rate of seroconversions in relation to age structure].
    Wangerin R; Diekamp U
    Beitr Infusionsther; 1988; 21():205-10. PubMed ID: 2462977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.